Envestnet Asset Management Inc. Has $3.94 Million Stock Holdings in Tempus AI, Inc. $TEM

Envestnet Asset Management Inc. increased its position in Tempus AI, Inc. (NASDAQ:TEM) by 2.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 62,005 shares of the company’s stock after purchasing an additional 1,558 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Tempus AI were worth $3,940,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of TEM. Bank of New York Mellon Corp increased its position in Tempus AI by 27.5% during the first quarter. Bank of New York Mellon Corp now owns 60,965 shares of the company’s stock worth $2,941,000 after buying an additional 13,142 shares during the last quarter. Signaturefd LLC bought a new position in shares of Tempus AI during the 1st quarter worth approximately $48,000. Massachusetts Financial Services Co. MA increased its holdings in shares of Tempus AI by 92.6% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock worth $27,926,000 after acquiring an additional 278,311 shares during the last quarter. Larson Financial Group LLC bought a new stake in Tempus AI in the 1st quarter valued at $53,000. Finally, Bridgewater Advisors Inc. acquired a new stake in Tempus AI during the 1st quarter valued at $259,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have commented on TEM shares. TD Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price objective on the stock. in a report on Tuesday, October 21st. BTIG Research reaffirmed a “buy” rating and set a $96.00 target price on shares of Tempus AI in a report on Wednesday, November 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Piper Sandler reduced their price objective on Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a report on Tuesday. Finally, Morgan Stanley upped their target price on Tempus AI from $68.00 to $80.00 and gave the company an “overweight” rating in a research report on Tuesday. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Hold” and a consensus target price of $80.00.

Tempus AI Stock Up 0.8%

TEM stock opened at $68.48 on Friday. The firm has a market capitalization of $11.90 billion, a PE ratio of -57.55 and a beta of 4.86. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32. The stock’s 50 day moving average is $85.16 and its 200-day moving average is $71.50.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The business had revenue of $334.21 million during the quarter, compared to analyst estimates of $328.89 million. During the same period in the prior year, the firm posted ($0.46) EPS. Tempus AI’s quarterly revenue was up 84.7% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Sell-side analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling

In other Tempus AI news, Director David R. Epstein sold 370 shares of the stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $90.00, for a total value of $33,300.00. Following the completion of the sale, the director owned 26,671 shares in the company, valued at approximately $2,400,390. This trade represents a 1.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $89.11, for a total transaction of $29,629,075.00. Following the transaction, the chief executive officer directly owned 9,074,532 shares in the company, valued at approximately $808,631,546.52. This represents a 3.53% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,061,282 shares of company stock valued at $84,650,781 over the last 90 days. 26.27% of the stock is currently owned by company insiders.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.